Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.
about
Cell Adhesion Molecules and Ubiquitination-Functions and SignificancePI3K and ERK signaling pathways are involved in differentiation of monocytic cells induced by 27-hydroxycholesterol.Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells.12-O-Tetradecanoylphorbol-13-acetate (TPA) is anti-tumorigenic in liver cancer cells via inhibiting YAP through AMOTAccuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review)The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.Self-renewal molecular mechanisms of colorectal cancer stem cells.A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker.Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.An HNF4α-microRNA-194/192 signaling axis maintains hepatic cell function.circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinomaHuaier Augmented the Chemotherapeutic Sensitivity of Oxaliplatin via Downregulation of YAP in Hepatocellular Carcinoma
P2860
Q26771983-81FF26F6-8E57-4F4B-976E-BD15B1B30105Q33614746-355A9873-38A6-4B35-B35E-4EFFD9C9C62FQ36414381-E350696E-442C-45B0-95E5-A00E50C41065Q37712962-E6AA5A5E-A80D-487B-8BC4-56DA526FCD83Q38859488-0113AA5E-A998-484A-8E05-0E17668E0970Q38904795-A7B92C90-803B-457D-B5E4-9D7555917AC6Q39026588-615FF7F9-78C2-4492-92C1-7295E9ADFA19Q39615435-B57A7C56-7B99-4A6B-89CA-E72A6F787A5DQ47948817-C7F523AD-85FA-484A-B46C-D5648D25DD8FQ48206950-7CD7C8ED-EAAD-4DA8-BFA9-A7E4EAD6EAF7Q49913406-53E4F7E6-7738-4663-90F5-6A2866A54B01Q51023566-CC1263C4-C5B9-4F77-80C9-2791A671C8DAQ58553877-C4A1671E-4BFB-4445-BBC8-9FFD86706705Q58576706-817B85A7-0654-4A66-92C8-5E194699CCD6
P2860
Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cluster of differentiation 166 ...... protein (YAP) in liver cancer.
@en
Cluster of differentiation 166
@nl
type
label
Cluster of differentiation 166 ...... protein (YAP) in liver cancer.
@en
Cluster of differentiation 166
@nl
prefLabel
Cluster of differentiation 166 ...... protein (YAP) in liver cancer.
@en
Cluster of differentiation 166
@nl
P2093
P2860
P356
P1476
Cluster of differentiation 166 ...... protein (YAP) in liver cancer
@en
P2093
Fenyong Sun
Jiafei Lin
Qiuhui Pan
Yongchun Yu
P2860
P304
P356
10.1074/JBC.M113.524819
P407
P50
P577
2014-01-30T00:00:00Z